Page last updated: 2024-08-24

oseltamivir and amantadine

oseltamivir has been researched along with amantadine in 175 studies

Research

Studies (175)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (2.29)	18.2507
2000's	90 (51.43)	29.6817
2010's	77 (44.00)	24.3611
2020's	4 (2.29)	2.80

Authors

Authors	Studies
De Clercq, E; Gawin, R; Koszytkowska-Stawińska, M; Naesens, L	1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E	1
Balzarini, J; Brancale, A; Cirilli, R; Coluccia, A; Giordano, C; La Regina, G; La Torre, F; Lavecchia, A; Maga, G; Novellino, E; Piscitelli, F; Samuele, A; Sansone, A; Silvestri, R; Zanoli, S	1
Batta, G; Herczegh, P; Kéki, S; Komáromi, I; Mándi, A; Naesens, L; Ostorházi, E; Pintér, G; Röth, E; Rozgonyi, F; Sztaricskai, F; Takács-Novák, K	1
Batta, G; Bereczki, I; Boda, Z; Herczegh, P; Naesens, L; Ostorházi, E; Otvös, R; Pintér, G; Roth, E; Rozgonyi, F; Szarvas, M; Sztaricskai, F	1
De Clercq, E; Ganguly, S; Kumar, KS; Veerasamy, R	1
Balzarini, J; De Clercq, E; Dewan, SK; Kumar, P; Narasimhan, B; Pannecouque, C; Yadav, S	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Balzarini, J; Bharatam, PV; Chibale, K; Kaur, H; Little, S; Singh, K	1
Achary, R; Han, SB; Jeong, HC; Jung, YS; Kim, JN; Kim, M; Kim, P; Kim, SY; Lee, CK; Malpani, Y	1
Balzarini, J; Chibale, K; Kaur, H; Singh, K	1
Balzarini, J; Singh, K	1
Fernández, R; Font-Bardia, M; Miquet, S; Naesens, L; Torres, E; Vanderlinden, E; Vázquez, S	1
Bandarage, UK; Bennani, YL; Bennett, HB; Bethiel, RS; Boyd, MJ; Bral, C; Byrn, RA; Charifson, PS; Clark, MP; Court, JJ; Davies, I; Deng, H; Dorsch, WA; Duffy, JP; Farmer, LJ; Gao, H; Germann, U; Gu, W; Jackson, K; Jacobs, DH; Jacobs, M; Jiang, M; Jones, SM; Kennedy, JM; Ledeboer, MW; Ledford, B; Leeman, JR; Liang, J; Maltais, F; McNeil, C; Memmott, C; Murcko, M; Nezami, A; Nti-Addae, K; Perola, E; Rijnbrand, R; Salituro, FG; Taylor, WP; Tsai, A; Wang, T; Wannamaker, MW; Zhang, Y	1
Chen, CH; Dang, Z; Huang, L; Jung, K; Lai, W; Lee, KH; Xie, H; Zhu, L	1
Chen, X; Lin, W; Liu, D; Proksch, P; Si, L; Zhang, L; Zhou, D	1
Batta, G; Bereczki, I; Borbás, A; Fizil, Á; Herczegh, P; Komáromi, I; Kurtán, T; Mándi, A; Naesens, L; Ostorházi, E; Rőth, E; Rozgonyi, F; Sipos, A; Sztaricskai, F; Vanderlinden, E	1
Chen, CH; Dang, Z; Huang, L; Jung, K; Lee, KH; Xie, H; Zhu, L	1
Lin, W; Liu, D; Niu, S; Shao, Z; Si, L; Wang, S; Zhang, L; Zhang, Z; Zhou, A; Zhou, D	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Cross, TA; Fedida, D; Freudenberger, K; Gauglitz, G; Hoffmann, A; Kolarov, F; Kolocouris, A; Schmidtke, M; Stylianakis, I; Tietjen, I; Tzitzoglaki, C; Wright, A	1
Busath, DD; Drakopoulos, A; Freudenberger, K; Gauglitz, G; Hoffmann, A; Hutterer, J; Kolocouris, A; Kolokouris, D; Konstantinidi, A; Ma, C; McGuire, K; Schmidtke, M; Tzitzoglaki, C; Wang, J	1
Cui, W; Dong, J; Du, Q; Hu, W; Hu, Y; Jiang, H; Li, R; Ma, C; Mok, CKP; Sun, P; Tu, Y; Wang, J; Wang, K; Xiao, M; Yang, C; Yang, Z; Zeng, S; Zhao, X; Zhou, Y	1
Andrei, G; Pertusati, F; Pileggi, E; Schols, D; Serpi, M; Snoeck, R	1
Orshanskaya, IR; Salakhutdinov, NF; Semenova, MD; Shtro, AA; Sokolova, AS; Yarovaya, OI; Zarubaev, VV	1
Dong, C; Jin, M; Li, S; Tang, Q; Wu, S; Xu, Z; Yu, Y; Zhao, Z; Zhou, HB	1
Balzarini, J; De Clercq, E; Karki, SS; Kulkarni, AA; Kumar, S; Veliyath, SK	1
Duan, Z; Gu, Q; Li, D; Li, J; Liu, Y; Wang, W; Wu, G; Yang, S; Yu, G; Yu, R; Yu, Y; Zhu, T	1
Cui, M; Hu, A; Li, S; Lian, W; Lin, D; Liu, A; Xiao, M; Xu, L; Yan, X; Ye, J; Zhang, M; Zhao, J	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Keating, MR	1
Couch, RB	1
Goldman, MP; Long, JK; Mossad, SB	1
Caserta, MT; Hall, CB	1
Ashley, JV; Gum, KD; Montalto, NJ	1
Rosen, DS	1
Briganti, E; Calza, L; Chiodo, F; Manfredi, R	1
Matsumoto, K	1
Tooley, P	1
Preboth, M	1
Holdiness, MR	1
Gross, PA	1
Hayden, FG	1
Farr, BM; Hall, KK; Hayden, FG; Salgado, CD	1
Cox, NJ; Fukuda, K; Uyeki, TM	1
Bowles, SK; Fearon, M; Lee, W; Li, Y; Loeb, M; McGeer, A; Simor, AE; Tamblyn, S; Vearncombe, M	1
Bridges, CB; Cox, NJ; Fukuda, K; Singleton, JA; Uyeki, TM	1
Prober, CG	1
Englund, JA	1
Fleming, DM	1
Uyeki, T; Winquist, A	1
Roberts, MS; Smith, KJ	1
Dumyati, G; Falsey, AR	1
Uyeki, TM	1
Balasingam, S; Bossuyt, S; Lambkin, R; Mann, A; Novelli, P; Oxford, JS	1
Sugaya, N	2
Mitamura, K	2
Kirkbride, HA; Watson, J	1
Bellantonio, S; Rose, DN; Rothberg, MB	1
Myers, JW	1
Kashiwagi, S	1
Hosoya, M; Imamura, T; Katayose, M; Kawasaki, Y; Oonishi, N; Sato, K; Suzuki, H	1
Pegram, PS; Williamson, JC	1
Di Natale, R; Guy, RJ; Hampson, AW; Kelly, HA; Lambert, SB; Robinson, PM; Tallis, G; Tobin, S	1
Kossow, KD; Lode, H; Ruf, BR; Scholz, H; Vogel, GE; Wutzler, P	1
Fagan, HB; Moeller, AH	1
Hansen, L	2
Benjamin, JH; Gardner, C; Green, K; Lee, W; Loeb, M; McArthur, M; McGeer, AJ; Simor, AE	1
Suzuki, H	1
Bowles, SK; McGeer, A; Oh, PI; Risebrough, NA; Simor, AE	1
Hirotsu, N; Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Kawashima, T; Maeda, T; Miyachi, K; Satoh, I; Shigematsu, T	1
Brandstaedt, A; Haertl, A; Sauerbrei, A; Schmidtke, M; Wutzler, P	1
Bovin, NV; Govorkova, EA; Ilyushina, NA; Webster, RG	1
Bonhoeffer, S; Regoes, RR	1
Le, MQ; Li, D; Masaki, H; Nguyen, HL; Nguyen, HT; Nguyen, TT; Phan, TV; Saito, R; Sato, M; Shimomura, C; Suzuki, H; Suzuki, Y	1
Mitamura, K; Sugaya, N	1
Barr, IG; Brown, L; Hurt, AC; Komadina, N; Selleck, P; Shaw, R	1
Dwyer, DE; Emery, S; Harrod, ME	1
Mossad, SB	1
Hayden, FG; Pavia, AT	1
Brydak, LB; Gawryluk, D; Machała, M; Wiatr, E	1
Bauer, K; Schmidtke, M; Schrader, C; Suess, J; Wutzler, P	1
Lynch, JP; Walsh, EE	1
Amonsin, A; Chaisingh, A; Chieochansin, T; Chutinimitkul, S; Damrongwatanapokin, S; Nuansrichay, B; Payungporn, S; Poovorawan, Y; Songserm, T; Suwannakarn, K; Theamboonlers, A	1
Govorkova, EA; Hoffmann, E; Ilyushina, NA; Salomon, R; Webster, RG	1
Finsterbusch, T; Hengel, H; Masihi, KN; Schweiger, B	1
Byun, YH; Kim, JH; Kim, SH; Lee, KH; Park, JH; Park, KD; Seong, BL; Song, JM	1
Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Kawamura, K; Kawashima, T	1
Wesseling, G	1
Amer, A; Evans, TG; Howard, D; Morrison, D; Rayner, C; Roy, S; Smith, JR	1
Moriuchi, H; Moriuchi, M	1
Worrall, G	1
Aziz, S; Garner, M; Huston, P; King, A; Li, Y; Macey, JF; Reyes, F; Winchester, B	1
Chidiac, C	1
Nüesch, R	1
Sugrue, RJ; Sutejo, R; Tan, BH; Yeo, DS	1
Ades, AE; Cooper, NJ; Lu, G; Sutton, AJ; Welton, NJ	1
Monto, AS	1
Bui, TN; Crusat, M; de Jong, MD; Do, HQ; Farrar, J; Fox, A; Hoang, PV; Horby, P; Le, MT; Luong, ST; Ngoc, BT; Nguyen, BG; Nguyen, CV; Nguyen, HD; Nguyen, HH; Nguyen, HL; Nguyen, HT; Nguyen, LT; Nguyen, T; Nguyen, TQ; Nguyen, TV; Pham, HV; Phan, PH; Taylor, W; Van, TD; Vuong, CD; Wertheim, HF	1
Balish, A; Bright, RA; Deyde, VM; Gubareva, LV; Klimov, AI; Lindstrom, S; Nguyen, T; Shu, B	1
Cooper, K; Jackson, R; Nicholson, K; Read, R; Rees, A; Simpson, E; Tappenden, P	1
Bailey, KW; Hurst, BL; Morrey, JD; Smee, DF; Wong, MH	1
Oxford, JS	1
Cheng, PK; Ho, EC; Lai, MY; Leung, PC; Leung, TW; Lim, WW; Ng, AY	1
Driebe, EM; Engelthaler, DM; Hoopes, JD; Keim, PS; Le, MH; Nguyen, JT; Prichard, MN; Smee, DF; Spence, RP; Went, GT	1
Auwanit, W; Bai, GR; Chittaganpitch, M; Ikuta, K; Kanai, Y; Li, YG; Sawanpanyalert, P	1
Nayak, JL; Treanor, JJ	1
Brown, EG; Farnsworth, A; Flaman, AS; Hashem, AM; He, R; Li, X; Van Domselaar, G	1
Cheng, PK; Lee, CW; Leung, PC; Leung, TW; Lim, WW; To, AP	1
Correia, V; de Andrade, HR; Lackenby, A; Santos, LA; Zambon, M	1
Baranovich, T; Caperig-Dapat, I; Dapat, C; Saito, R; Suzuki, H; Suzuki, Y; Zaraket, H	1
Blair, PJ; de Jong, MD; Faix, DJ; Hoopes, JD; Le, MH; Nguyen, JT; Patick, AK; Prichard, MN; Smee, DF; Went, GT	1
Greer, LG; McIntire, DD; Roberts, SW; Rogers, VL; Sheffield, JS; Wendel, GD	1
Fujita, N; Horikawa, H; Kageyama, T; Kato, Y; Kishida, N; Mochizuki, K; Obuchi, M; Odagiri, T; Shimabukuro, K; Shirakura, M; Tashiro, M; Ujike, M; Yamashita, K	1
Baranovich, T; Caperig-Dapat, I; Dapat, C; Dbaibo, GS; Medlej, F; Reda, M; Saito, R; Suzuki, H; Suzuki, Y; Tabet, C; Wakim, R; Zaraket, H	1
Ghosh, GC; Nakada, N; Tanaka, H; Yamashita, N	1
Lundgren, J; Madsen, L; Nielsen, A	1
Chang, KO; Kim, Y; Narayanan, S	1
Hatakeyama, S	1
Ishii, H; Kadota, J; Tokimatsu, I; Yoshioka, D	1
Watanabe, A	1
Cooper, KL; Jackson, RJ; Nicholson, KG; Read, RC; Rees, A; Simpson, EL; Tappenden, P	1
Casas, I; González-Vincent, M; Pérez-Breña, P; Pozo, F; Ruiz-Carrascoso, G	1
Li, JF; Shen, JS; Xiong, RS; Zhang, Q; Zhao, QJ	1
Hankins, RW; Hattori, H; Iida, H; Miyachi, K; Takano, T; Ukai, H; Watanabe, A	1
Razonable, RR	1
Choi, SH; Chon, GR; Han, MS; Hong, SB; Huh, JW; Kim, HR; Kim, MJ; Kim, SH; Kim, WY; Kim, YS; Ko, YG; Lee, KH; Ryu, YJ; Young Suh, G	1
Arnold, K; Baumbach, J; Bennett, NM; Doshi, S; Finelli, L; Fry, AM; Gershman, K; Hancock, EB; Kamimoto, L; Lynfield, R; Morin, C; Perez, A; Reingold, A; Ryan, P; Schaffner, W; Thomas, A; Yousey-Hindes, K; Zansky, S	1
Driebe, EM; Engelthaler, DM; Hoopes, JD; Keim, PS; Kelley, E; Nguyen, JT; Perelson, AS; Rong, L; Went, GT	1
Barnard, DL; de Jong, MD; Gross, M; Julander, JG; Nguyen, JT; Smee, DF; Went, GT	1
Chen, J; Cheng, H; Cheng, YS; Ding, K; Lin, MI; Liu, J; Liu, Y; Lu, X; Tu, Z; Wan, J; Xu, Y	1
Baumeister, E; Campos, AM; Pontoriero, A; Savy, VL	1
Akl, EA; Alonso-Coello, P; Brozek, J; Chen, YL; Cheung, A; Flottorp, SA; Hopkins, JP; Hovhannisyan, G; Hsu, J; Ivanova, L; Mustafa, R; Saeterdal, I; Santesso, N; Schünemann, HJ; Smaill, F; Tian, J; Uyeki, TM; Wong, AD	1
Gross, M; Julander, JG; Nguyen, J; Smee, DF; Tarbet, EB	1
Azuma, T; Nakada, N; Tanaka, H; Yamashita, N	2
Sato, R	1
Dapat, C; Dapat, IC; Hasegawa, G; Kyaw, Y; Myint, YY; Naito, M; Oo, HN; Oo, KY; Saito, R; Suzuki, H	1
Cen, S; He, Z; Li, XY; Liu, ZL; Wang, X; Wang, Z; Wei, XL; Yin, X; Zhang, ZZ; Zhou, JM	1
Boeckh, MJ; de Jong, MD; Englund, JA; Lindegardh, N; Nguyen, JT; Pukrittayakamee, S; Renaud, C; Seo, S; Tambyah, PA; Tarning, J; Went, GT	1
Chen, S; Liu, Q; Wang, D; Wang, S; Zhang, Y	1
Chen, HW; Cheng, JX; King, K; Liu, MT; Liu, YT; Peng, JY; Schooley, RT; Shresta, S; Wang, CH; Zhang, XQ	1
Jang, HC; Jung, SI; Kang, SJ; Kee, SJ; Kwon, YS; Park, KH; Shin, JH	1
Cai, J; Wang, X; Yao, W; Zeng, M; Zhao, B; Zhu, Q	1
Deryabin, PG; Galegov, GA; Konstantinova, ID; L'vov, DK; Miroshnikov, AI; Muzyka, IS	1
Król, E; Rychłowska, M; Szewczyk, B	1
Abraham, A; Bishwas, D; Broor, S; Chadha, MS; Chawla-Sarkar, M; Dakhave, MR; Gunashekaran, P; Kadam, AA; Kode, SS; Kulkarni, PB; Mishra, AC; Patil, KN; Potdar, VA; Tikhe, SA	1
Ali, Z; Dapat, C; Dapat, IC; Dbaibo, G; Ghanem, S; Kayali, G; Kondo, H; Lteif, M; Saito, K; Saito, R; Suzuki, H; Zaraket, H	1
Chintakrindi, AS; Chowdhary, AS; Deshmukh, RA; Gohil, DJ; Kanyalkar, MA; Kothari, ST; Meharunkar, R; Shinde, PS; Warke, RV	1
Li, F; Ma, C; Wang, J	1
Chen, HL; Guan, Y	1
Fry, AM; McKimm-Breschkin, JL	1
Ma, C; Wang, J; Zhang, J	1
Ariza-Heredia, EJ; Chemaly, RF; Shahani, L	1
Li, G; Li, Z; Qian, M; Wang, J; Wu, H; Xia, W; Yang, H; Zeng, Y	1
Bao, Y; Beasley, RL; Beeler, J; Beigel, JH; Bozzolo, DR; Dar, SM; Davey, RT; Holley, HP; Hoopes, J; Hughes, MD; Lane, HC; Losso, MH; Manosuthi, W; McClure, N; Myers, C; Panuto, J; Perez-Patrigeon, S; Slandzicki, A; Suwanpimolkul, G	1
Behzadian, F; Kananizadeh, P; Moeini, S; Mozhgani, SH; Pakzad, R; Zarei Ghobadi, M	1
Fukushima, A; Okamura, M; Ono, H	1
Ono, H	1
Bai, H; Ingber, DE; Jin, L; Oh, CY; Prantil-Baun, R; Si, L	1

Reviews

57 review(s) available for oseltamivir and amantadine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Antiviral agents for non-human immunodeficiency virus infections. Mayo Clinic proceedings, 1999, Volume: 74, Issue:12 Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir	1999
Measures for control of influenza. PharmacoEconomics, 1999, Volume: 16 Suppl 1 Topics: Amantadine; Amines; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	1999
Antiviral agents for treating influenza. Cleveland Clinic journal of medicine, 2000, Volume: 67, Issue:2 Topics: Acetamides; Amantadine; Antiviral Agents; Drug Administration Schedule; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2000
Updated treatment for influenza A and B. American family physician, 2000, Dec-01, Volume: 62, Issue:11 Topics: Acetamides; Amantadine; Antiviral Agents; Clinical Trials as Topic; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Treatment Outcome; Zanamivir	2000
[Influenza]. Recenti progressi in medicina, 2000, Volume: 91, Issue:12 Topics: Acetamides; Amantadine; Antiviral Agents; Disease Outbreaks; Guanidines; History, 18th Century; History, 19th Century; History, 20th Century; Humans; Influenza, Human; Italy; Orthomyxoviridae; Oseltamivir; Pyrans; Sialic Acids; United States; Zanamivir	2000
[Antiinfluenza-drugs and the standard of the use]. Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:11 Topics: Acetamides; Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Sialic Acids; Zanamivir	2000
Adverse cutaneous reactions to influenza vaccinations and chemotherapy. International journal of dermatology, 2001, Volume: 40, Issue:7 Topics: Acetamides; Amantadine; Antiviral Agents; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Orthomyxoviridae; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Skin; Zanamivir	2001
Vaccines for pneumonia and new antiviral therapies. The Medical clinics of North America, 2001, Volume: 85, Issue:6 Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Centers for Medicare and Medicaid Services, U.S.; Child; Global Health; Guanidines; Health Priorities; Humans; Incidence; Influenza Vaccines; Joint Commission on Accreditation of Healthcare Organizations; Morbidity; Neuraminidase; Oseltamivir; Patient Selection; Pneumococcal Vaccines; Pneumonia; Primary Prevention; Pyrans; Rimantadine; Safety; Sialic Acids; United States; Vaccination; Zanamivir	2001
Perspectives on antiviral use during pandemic influenza. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2001, Dec-29, Volume: 356, Issue:1416 Topics: Acetamides; Amantadine; Antiviral Agents; Chemoprevention; Disease Outbreaks; Drug Resistance, Multiple, Viral; Drug Tolerance; Guanidines; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2001
Influenza in the acute hospital setting. The Lancet. Infectious diseases, 2002, Volume: 2, Issue:3 Topics: Acetamides; Amantadine; Antiviral Agents; Cross Infection; Disease Outbreaks; Guanidines; Hospitals; Humans; Influenza Vaccines; Influenza, Human; Nursing Staff, Hospital; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Vaccination; Virginia; Zanamivir	2002
Antiviral therapy for influenza virus infections. Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:1 Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Child; Clinical Trials as Topic; Global Health; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2002
Antiviral therapy of influenza. Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:2 Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Drug Resistance, Viral; Guanidines; Humans; Infant; Influenza, Human; Orthomyxoviridae; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2002
The management of influenza in people of working age. Occupational medicine (Oxford, England), 2002, Volume: 52, Issue:5 Topics: Acetamides; Adolescent; Adult; Amantadine; Antiviral Agents; Cost-Benefit Analysis; Guanidines; Humans; Influenza, Human; Middle Aged; Occupational Health; Oseltamivir; Pyrans; Sialic Acids; United Kingdom; Workplace; Zanamivir	2002
Influenza. Clinical evidence, 2002, Issue:7 Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Randomized Controlled Trials as Topic; Rimantadine; Sialic Acids; Treatment Outcome; Zanamivir	2002
Antivirals for influenza: what is their role in the older patient? Drugs & aging, 2002, Volume: 19, Issue:10 Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Drug Resistance, Viral; Guanidines; Humans; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2002
Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. The Pediatric infectious disease journal, 2003, Volume: 22, Issue:2 Topics: Acetamides; Adolescent; Age Distribution; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; DNA, Viral; Female; Fluorescent Antibody Technique, Direct; Follow-Up Studies; Guanidines; Humans; Incidence; Infant; Influenza, Human; Male; Orthomyxoviridae; Oseltamivir; Pyrans; Risk Assessment; Severity of Illness Index; Sex Distribution; Sialic Acids; Treatment Outcome; United States; Zanamivir	2003
Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:1 Topics: Acetamides; Amantadine; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Endemic Diseases; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Viral Matrix Proteins; Zanamivir	2003
[Influenza]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: Acetamides; Amantadine; Antiviral Agents; Diagnosis, Differential; Enzyme Inhibitors; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Reagent Kits, Diagnostic; Sialic Acids; Vaccines, Attenuated; Zanamivir	2003
[Antiviral agents for influenza]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Viral Matrix Proteins; Zanamivir	2003
Review of the use of neuraminidase inhibitors for prophylaxis of influenza. Communicable disease and public health, 2003, Volume: 6, Issue:2 Topics: Acetamides; Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Health Planning; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Practice Guidelines as Topic; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2003
Influenza therapy. Southern medical journal, 2003, Volume: 96, Issue:8 Topics: Acetamides; Adult; Age Factors; Amantadine; Antiviral Agents; Child; Cost-Benefit Analysis; Creatine; Disease Outbreaks; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Influenza, Human; Kidney Failure, Chronic; Metabolic Clearance Rate; Oseltamivir; Patient Selection; Primary Prevention; Pyrans; Sialic Acids; Treatment Outcome; Zanamivir	2003
[Criteria for the use of anti-influenza agents]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:11 Topics: Acetamides; Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Practice Guidelines as Topic; Prodrugs; Pyrans; Sialic Acids; Time Factors; Virus Latency; Zanamivir	2003
Neuraminidase inhibitors in patients with underlying airways disease. American journal of respiratory medicine : drugs, devices, and other interventions, 2002, Volume: 1, Issue:2 Topics: Acetamides; Amantadine; Antiviral Agents; Asthma; Bronchial Spasm; Comorbidity; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Product Surveillance, Postmarketing; Pulmonary Disease, Chronic Obstructive; Pyrans; Rimantadine; Risk Factors; Sialic Acids; Zanamivir	2002
What is the best antiviral agent for influenza infection? American family physician, 2004, Oct-01, Volume: 70, Issue:7 Topics: Acetamides; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Contraindications; Evidence-Based Medicine; Family Practice; Guanidines; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2004
Influenza. Clinical evidence, 2003, Issue:10 Topics: Acetamides; Adult; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2003
[Super pathogenic avian influenza]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2004, Nov-10, Volume: 93, Issue:11 Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Chickens; Disease Outbreaks; Guanidines; Humans; Influenza A virus; Influenza in Birds; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Poultry Diseases; Pyrans; Sialic Acids; Zanamivir; Zoonoses	2004
Influenza. Clinical evidence, 2004, Issue:12 Topics: Acetamides; Adult; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2004
[Anti-virals for influenza virus infection]. Uirusu, 2005, Volume: 55, Issue:1 Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Drug Utilization; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Japan; National Health Programs; Neuraminidase; Oseltamivir; Pyrans; Sialic Acids; Zanamivir	2005
[Diagnosis and Treatment of influenza--clinical investigation on viral shedding in children with influenza]. Uirusu, 2006, Volume: 56, Issue:1 Topics: Amantadine; Antiviral Agents; Child; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Point-of-Care Systems; Reagent Kits, Diagnostic; Time Factors; Viral Load; Virology; Virus Shedding	2006
Antivirals in the management of an influenza pandemic. The Medical journal of Australia, 2006, 11-20, Volume: 185, Issue:S10 Topics: Amantadine; Antiviral Agents; Australia; Community-Acquired Infections; Disease Outbreaks; Drug Resistance, Viral; Government Programs; Humans; Infection Control; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; World Health Organization; Zanamivir	2006
Which agents should we use to treat and prevent influenza in 2006-2007? Cleveland Clinic journal of medicine, 2006, Volume: 73, Issue:11 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Zanamivir	2006
Antiviral therapy and prophylaxis for influenza in children. Pediatrics, 2007, Volume: 119, Issue:4 Topics: Adamantane; Amantadine; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Influenza, Human; Male; Oseltamivir; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Rimantadine; Risk Assessment; Severity of Illness Index; Treatment Outcome; Zanamivir	2007
[Antiviral agents for influenza]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Viral Matrix Proteins; Zanamivir	2007
Influenza: evolving strategies in treatment and prevention. Seminars in respiratory and critical care medicine, 2007, Volume: 28, Issue:2 Topics: Aged; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Child, Preschool; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Ribavirin; Rimantadine; United States; Zanamivir	2007
Occasional review: influenza in COPD: pathogenesis, prevention, and treatment. International journal of chronic obstructive pulmonary disease, 2007, Volume: 2, Issue:1 Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Rimantadine; Zanamivir	2007
[Adverse effects of antiviral agents]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8 Topics: Acyclovir; Amantadine; Anti-HIV Agents; Antiviral Agents; Cytomegalovirus Infections; Herpes Simplex; Herpes Zoster; HIV Infections; Humans; Influenza, Human; Oseltamivir; Protease Inhibitors; Reverse Transcriptase Inhibitors	2007
[Influenza]. La Revue du praticien, 2008, Feb-29, Volume: 58, Issue:4 Topics: Adolescent; Adult; Age Factors; Aged; Amantadine; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Diagnosis, Differential; Female; Follow-Up Studies; France; Humans; Infant; Influenza Vaccines; Influenza, Human; Male; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Seasons; Time Factors; Treatment Outcome; Zanamivir	2008
[Antiviral treatment of influenza in humans]. Therapeutische Umschau. Revue therapeutique, 2007, Volume: 64, Issue:11 Topics: Amantadine; Animals; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Virus Replication; Virus Shedding; Zanamivir	2007
Antiviral drugs for the control of pandemic influenza virus. Annals of the Academy of Medicine, Singapore, 2008, Volume: 37, Issue:6 Topics: Amantadine; Animals; Antiviral Agents; Birds; Disease Outbreaks; Global Health; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Oseltamivir; RNA, Small Interfering	2008
Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation. Health technology assessment (Winchester, England), 2009, Volume: 13, Issue:11 Topics: Amantadine; Antiviral Agents; Cost-Benefit Analysis; Humans; Influenza, Human; Models, Economic; Oseltamivir; Practice Guidelines as Topic; Premedication; Randomized Controlled Trials as Topic; Seasons; Treatment Outcome; Zanamivir	2009
Antivirals for the treatment and prevention of epidemic and pandemic influenza. Influenza and other respiratory viruses, 2007, Volume: 1, Issue:1 Topics: Amantadine; Antiviral Agents; Chemoprevention; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza, Human; Oseltamivir; Rimantadine; Zanamivir	2007
Antiviral treatment and prophylaxis of influenza virus in children. Pediatric annals, 2009, Volume: 38, Issue:12 Topics: Amantadine; Antiviral Agents; Chemoprevention; Child; Child, Preschool; Enzyme Inhibitors; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Post-Exposure Prophylaxis; Zanamivir	2009
[Drug-resistant influenza viruses: an overview]. Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68, Issue:9 Topics: Amantadine; Animals; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir	2010
[Current anti-influenza virus chemotherapy]. Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68, Issue:9 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Drug Utilization; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Infusions, Intravenous; Japan; Oseltamivir; Pandemics; Zanamivir	2010
[Present and future in development of new anti-influenza drugs]. Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68, Issue:9 Topics: Amantadine; Antiviral Agents; DNA-Directed RNA Polymerases; Drug Design; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Zanamivir	2010
Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review. The Journal of infection, 2011, Volume: 62, Issue:1 Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Humans; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Post-Exposure Prophylaxis; Treatment Outcome; Viral Matrix Proteins; Zanamivir	2011
[Research progress of anti-influenza virus agents]. Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:3 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Guanidines; Humans; Indoles; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Pyrrolidines; Rimantadine; Structure-Activity Relationship; Viral Matrix Proteins; Zanamivir	2010
Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clinic proceedings, 2011, Volume: 86, Issue:10 Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir	2011
Antiviral drugs for influenza. The Medical letter on drugs and therapeutics, 2012, Jan-09, Volume: 54, Issue:1381 Topics: Adult; Amantadine; Antiviral Agents; Child; Female; Humans; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Pregnancy; Rimantadine; Zanamivir	2012
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Annals of internal medicine, 2012, Apr-03, Volume: 156, Issue:7 Topics: Administration, Inhalation; Administration, Oral; Amantadine; Antiviral Agents; Confounding Factors, Epidemiologic; Hospitalization; Humans; Influenza, Human; Oseltamivir; Rimantadine; Treatment Outcome; Zanamivir	2012
[Drug resistance of influenza viruses]. Nihon Jibiinkoka Gakkai kaiho, 2012, Volume: 115, Issue:7 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Neuraminidase; Oseltamivir; Pyrans; Sialic Acids; Viral Matrix Proteins; Zanamivir	2012
Antivirals--current trends in fighting influenza. Acta biochimica Polonica, 2014, Volume: 61, Issue:3 Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Viral Matrix Proteins; Zanamivir	2014
Inhibitors targeting the influenza virus hemagglutinin. Current medicinal chemistry, 2015, Volume: 22, Issue:11 Topics: Amantadine; Antiviral Agents; Enzyme Inhibitors; Hemagglutinin Glycoproteins, Influenza Virus; Neuraminidase; Orthomyxoviridae; Oseltamivir; Rimantadine; Zanamivir	2015
Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert review of anti-infective therapy, 2017, Volume: 15, Issue:4 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Coronavirus Infections; Cyclopentanes; Guanidines; Humans; Immunocompromised Host; Influenza, Human; Oseltamivir; Palivizumab; Paramyxoviridae Infections; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Zanamivir	2017
Prevalence of human influenza virus in Iran: Evidence from a systematic review and meta-analysis. Microbial pathogenesis, 2018, Volume: 115 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Female; Humans; Incidence; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Iran; Male; Oseltamivir; Prevalence; Zanamivir	2018
[Hypothermic Action of Oseltamivir Not Dependent on Its Anti-influenza Virus Action]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2019, Volume: 139, Issue:5 Topics: Adipose Tissue, Brown; Amantadine; Animals; Antipyretics; Antiviral Agents; Body Temperature; Dose-Response Relationship, Drug; Humans; Hypothermia; Mice; Oseltamivir; Rats; Receptors, Dopamine D2; Receptors, Nicotinic	2019

Trials

4 trial(s) available for oseltamivir and amantadine

Article	Year
[The study on efficacy of oseltamivir for influenza A in children]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2003, Volume: 77, Issue:11 Topics: Acetamides; Amantadine; Analgesics, Non-Narcotic; Antiviral Agents; Child, Preschool; Female; Humans; Influenza A virus; Influenza, Human; Male; Oseltamivir	2003
A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination. PloS one, 2007, Dec-12, Volume: 2, Issue:12 Topics: Adolescent; Adult; Amantadine; Antiviral Agents; Area Under Curve; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Oseltamivir	2007
Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics. Antiviral therapy, 2013, Volume: 18, Issue:3 Topics: Adult; Amantadine; Drug Resistance, Viral; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Influenza A virus; Influenza, Human; Male; Mutation; Oseltamivir; Pilot Projects; Ribavirin; Viral Load; Young Adult	2013
Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial. The Lancet. Infectious diseases, 2017, Volume: 17, Issue:12 Topics: Amantadine; Antiviral Agents; Argentina; Australia; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Influenza, Human; Male; Mexico; Oseltamivir; Ribavirin; Thailand; United States	2017

Other Studies

114 other study(ies) available for oseltamivir and amantadine

Article	Year
Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structure. Bioorganic & medicinal chemistry, 2008, Sep-15, Volume: 16, Issue:18 Topics: Animals; Antiviral Agents; Aza Compounds; Catalysis; Cell Line; DNA Viruses; Drug Resistance, Viral; Humans; Hydrogenation; Nucleosides; Palladium; Pyrimidine Nucleosides; RNA Viruses; Structure-Activity Relationship; Sulfanilamide; Sulfanilamides	2008
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2 Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship	2009
Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus. Journal of medicinal chemistry, 2009, Apr-09, Volume: 52, Issue:7 Topics: Amino Acids; Animals; Anti-HIV Agents; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Cell Proliferation; Cytostatic Agents; Drug Resistance, Viral; Enterovirus B, Human; HIV Reverse Transcriptase; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Indoles; Lymphocytes; Mice; Models, Molecular; Molecular Conformation; Mutation; Protein Binding; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Sulfones; Virus Replication	2009
Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study. Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19 Topics: Anti-Bacterial Agents; Antiviral Agents; Diazonium Compounds; Doxorubicin; Gram-Positive Bacteria; Microbial Sensitivity Tests; Orthomyxoviridae; Teicoplanin	2009
Click reaction synthesis of carbohydrate derivatives from ristocetin aglycon with antibacterial and antiviral activity. Bioorganic & medicinal chemistry letters, 2010, May-01, Volume: 20, Issue:9 Topics: Anti-Bacterial Agents; Antiviral Agents; Catalysis; Copper; Doxorubicin; Humans; Influenza A Virus, H1N1 Subtype; Microbial Sensitivity Tests; Ristocetin	2010
Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones. European journal of medicinal chemistry, 2010, Volume: 45, Issue:11 Topics: Antiviral Agents; Cell Line; Drug Evaluation, Preclinical; Humans; Magnetic Resonance Spectroscopy; Quinazolines; Schiff Bases; Spectrophotometry, Infrared	2010
4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation. European journal of medicinal chemistry, 2010, Volume: 45, Issue:12 Topics: Animals; Anti-Infective Agents; Benzenesulfonates; Cell Survival; Cells, Cultured; Chlorocebus aethiops; Dogs; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Quantitative Structure-Activity Relationship; Stereoisomerism; Structure-Activity Relationship; Vero Cells; Viruses	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies. European journal of medicinal chemistry, 2012, Volume: 52 Topics: Aminoquinolines; Animals; Antimalarials; Cell Line; DNA; Dogs; Heme; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Plasmodium falciparum; Protoporphyrins; Pyrimidines; Structure-Activity Relationship; Viruses	2012
Efficient synthesis of 3H,3'H-spiro[benzofuran-2,1'-isobenzofuran]-3,3'-dione as novel skeletons specifically for influenza virus type B inhibition. European journal of medicinal chemistry, 2013, Volume: 62 Topics: Antiviral Agents; Benzofurans; Dose-Response Relationship, Drug; Influenza B virus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship	2013
Synthesis of 4-aminoquinoline-pyrimidine hybrids as potent antimalarials and their mode of action studies. European journal of medicinal chemistry, 2013, Volume: 66 Topics: Antimalarials; Antiviral Agents; Cell Line; Chemistry Techniques, Synthetic; DNA; Heme; Humans; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship	2013
Regioselective synthesis of 6-substituted-2-amino-5-bromo-4(3H)-pyrimidinones and evaluation of their antiviral activity. European journal of medicinal chemistry, 2013, Volume: 67 Topics: Animals; Antiviral Agents; Cells, Cultured; Chlorocebus aethiops; Dogs; Dose-Response Relationship, Drug; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidinones; Stereoisomerism; Structure-Activity Relationship; Vero Cells; Viruses	2013
Synthesis and Anti-influenza A Virus Activity of 2,2-Dialkylamantadines and Related Compounds. ACS medicinal chemistry letters, 2012, Dec-13, Volume: 3, Issue:12 Topics:	2012
Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2. Journal of medicinal chemistry, 2014, Aug-14, Volume: 57, Issue:15 Topics: Administration, Oral; Animals; Antiviral Agents; Aza Compounds; Biological Availability; Dogs; Drug Resistance, Viral; Indoles; Influenza A virus; Madin Darby Canine Kidney Cells; Male; Mice, Inbred BALB C; Models, Molecular; Molecular Structure; Orthomyxoviridae Infections; Rats; RNA-Dependent RNA Polymerase; Species Specificity; Stereoisomerism; Structure-Activity Relationship; Viral Proteins; Virus Replication	2014
Identification and synthesis of quinolizidines with anti-influenza a virus activity. ACS medicinal chemistry letters, 2014, Aug-14, Volume: 5, Issue:8 Topics:	2014
Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin. European journal of medicinal chemistry, 2015, Mar-26, Volume: 93 Topics: Alkaloids; Animals; Antiviral Agents; Cell Line, Tumor; Cell Survival; Cytopathogenic Effect, Viral; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Viral; Eurotium; HEK293 Cells; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Molecular Structure; Piperazines; Structure-Activity Relationship; Viral Plaque Assay	2015
A few atoms make the difference: synthetic, CD, NMR and computational studies on antiviral and antibacterial activities of glycopeptide antibiotic aglycon derivatives. European journal of medicinal chemistry, 2015, Apr-13, Volume: 94 Topics: Anti-Bacterial Agents; Antiviral Agents; Chemistry Techniques, Synthetic; Circular Dichroism; Computer Simulation; Magnetic Resonance Spectroscopy; Orthomyxoviridae; Protein Conformation; Ristocetin; Structure-Activity Relationship; Teicoplanin	2015
Phenolic diterpenoid derivatives as anti-influenza a virus agents. ACS medicinal chemistry letters, 2015, Mar-12, Volume: 6, Issue:3 Topics:	2015
Spiromastilactones: A new class of influenza virus inhibitors from deep-sea fungus. European journal of medicinal chemistry, 2016, Jan-27, Volume: 108 Topics: Animals; Antiviral Agents; Aquatic Organisms; Benzofurans; Dogs; Dose-Response Relationship, Drug; Influenza A virus; Lactones; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Onygenales; Structure-Activity Relationship	2016
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Binding and Proton Blockage by Amantadine Variants of the Influenza M2 Journal of medicinal chemistry, 2017, 03-09, Volume: 60, Issue:5 Topics: Amantadine; Antiviral Agents; Influenza A virus; Ligands; Protons; Spectrum Analysis; Viral Matrix Proteins	2017
Unraveling the Binding, Proton Blockage, and Inhibition of Influenza M2 WT and S31N by Rimantadine Variants. ACS medicinal chemistry letters, 2018, Mar-08, Volume: 9, Issue:3 Topics:	2018
Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses. Journal of medicinal chemistry, 2018, 06-28, Volume: 61, Issue:12 Topics: Amantadine; Antiviral Agents; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Viral; Enzyme Inhibitors; Hemagglutinins; Imidazoles; Influenza A virus; Microbial Sensitivity Tests; Molecular Conformation; Neuraminidase; Oseltamivir; Structure-Activity Relationship	2018
Expedient synthesis and biological evaluation of alkenyl acyclic nucleoside phosphonate prodrugs. Bioorganic & medicinal chemistry, 2018, 07-23, Volume: 26, Issue:12 Topics: Antiviral Agents; Cell Line; DNA Viruses; Drug Stability; Humans; Nucleosides; Organophosphonates; Prodrugs; RNA Viruses; Structure-Activity Relationship	2018
Synthesis and MedChemComm, 2017, May-01, Volume: 8, Issue:5 Topics:	2017
Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors. European journal of medicinal chemistry, 2018, Nov-05, Volume: 159 Topics: Animals; Antifungal Agents; Antiviral Agents; Cell Proliferation; Dogs; Dose-Response Relationship, Drug; Humans; Influenza A Virus, H5N1 Subtype; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Saccharomyces cerevisiae; Structure-Activity Relationship; Sulfonamides	2018
Synthesis and biological evaluation of 2-(5-substituted-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, 2013, Volume: 22, Issue:4 Topics:	2013
Chemoreactive-Inspired Discovery of Influenza A Virus Dual Inhibitor to Block Hemagglutinin-Mediated Adsorption and Membrane Fusion. Journal of medicinal chemistry, 2020, 07-09, Volume: 63, Issue:13 Topics: Acetophenones; Adsorption; Animals; Antiviral Agents; Dogs; Drug Discovery; Drug Resistance, Viral; Female; Hemagglutinin Glycoproteins, Influenza Virus; Influenza A virus; Madin Darby Canine Kidney Cells; Membrane Fusion; Mice; Tissue Distribution; Virus Internalization; Virus Replication	2020
Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors. European journal of medicinal chemistry, 2021, Mar-05, Volume: 213 Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Influenza A Virus, H3N2 Subtype; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Neuraminidase; Structure-Activity Relationship; Thiazoles	2021
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Two neuraminidase inhibitors for treatment of influenza. The Medical letter on drugs and therapeutics, 1999, Oct-08, Volume: 41, Issue:1063 Topics: Acetamides; Administration, Inhalation; Administration, Oral; Amantadine; Amines; Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Prodrugs; Pyrans; Sialic Acids; Zanamivir	1999
Drugs for non-HIV viral infections. The Medical letter on drugs and therapeutics, 1999, Dec-03, Volume: 41, Issue:1067 Topics: 2-Aminopurine; Acetamides; Acyclovir; Aged; Amantadine; Animals; Anti-HIV Agents; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enzyme Inhibitors; Famciclovir; Ganciclovir; Guanidines; Guanine; Herpes Simplex; Herpes Zoster; History, 18th Century; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Lamivudine; Neuraminidase; Oseltamivir; Pyrans; Rats; Ribavirin; Sialic Acids; Teratogens; Valacyclovir; Valine; Zanamivir	1999
Antiviral agents for influenza. Pediatric annals, 2000, Volume: 29, Issue:11 Topics: Acetamides; Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Guanidines; Guidelines as Topic; Humans; Infant; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Randomized Controlled Trials as Topic; Sialic Acids; Treatment Outcome; Zanamivir	2000
Flu-fighting options: decisions, decisions.... Health news (Waltham, Mass.), 2000, Volume: 6, Issue:12 Topics: Acetamides; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza, Human; Oseltamivir; Pneumonia; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2000
Unprepared for an influenza pandemic. Lancet (London, England), 2001, Aug-25, Volume: 358, Issue:9282 Topics: Acetamides; Amantadine; Antiviral Agents; Disease Outbreaks; Drug Resistance, Microbial; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Sialic Acids; Zanamivir	2001
ACIP releases guidelines on the prevention and control of influenza. Advisory Committee on Immunization Practices. American family physician, 2001, Oct-01, Volume: 64, Issue:7 Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Drug Administration Schedule; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Patient Selection; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2001
Influenza surveillance with rapid diagnostic tests. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, May-15, Volume: 34, Issue:10 Topics: Acetamides; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Population Surveillance; Rimantadine; United States	2002
Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. Journal of the American Geriatrics Society, 2002, Volume: 50, Issue:4 Topics: Acetamides; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Disease Outbreaks; Female; Humans; Influenza Vaccines; Influenza, Human; Long-Term Care; Male; Middle Aged; Nursing Homes; Ontario; Oseltamivir; Treatment Outcome	2002
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2002, Apr-12, Volume: 51, Issue:RR-3 Topics: Acetamides; Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Cost-Benefit Analysis; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Rimantadine; Risk Factors; Sialic Acids; United States; Vaccination; Zanamivir	2002
Cost-effectiveness of newer treatment strategies for influenza. The American journal of medicine, 2002, Volume: 113, Issue:4 Topics: Acetamides; Adult; Age Distribution; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Cost-Benefit Analysis; Decision Trees; Diagnostic Tests, Routine; Drug Costs; Female; Guanidines; Humans; Influenza, Human; Male; Middle Aged; Monte Carlo Method; Neuraminidase; Oseltamivir; Pennsylvania; Pyrans; Quality-Adjusted Life Years; Sialic Acids; Zanamivir	2002
Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Annals of internal medicine, 2003, Sep-02, Volume: 139, Issue:5 Pt 1 Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir	2003
Summaries for patients. Cost-effective management of flu in adults older than 65 years of age. Annals of internal medicine, 2003, Sep-02, Volume: 139, Issue:5 Pt 1 Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir	2003
Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapy. The Medical journal of Australia, 2004, Jun-21, Volume: 180, Issue:12 Topics: Acetamides; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Disease Outbreaks; Female; Guanidines; Homes for the Aged; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Influenza A virus; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Sialic Acids; Vaccination; Victoria; Zanamivir	2004
Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 31, Issue:2 Topics: Acetamides; Amantadine; Antiviral Agents; Drug Resistance, Viral; Germany; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Primary Health Care; Pyrans; Sialic Acids; Zanamivir	2004
Avian influenza should be ruffling our feathers. The Lancet. Infectious diseases, 2004, Volume: 4, Issue:10 Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Asia, Eastern; Asia, Southeastern; Birds; Disease Outbreaks; Guanidines; Humans; Influenza in Birds; Influenza Vaccines; Influenza, Human; International Cooperation; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; World Health Organization; Zanamivir	2004
Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults. Infection control and hospital epidemiology, 2004, Volume: 25, Issue:11 Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Child; Comorbidity; Developmental Disabilities; Disease Outbreaks; Female; Gastrointestinal Diseases; Humans; Incidence; Infection Control; Long-Term Care; Male; Middle Aged; Nervous System Diseases; Ontario; Oseltamivir; Respiratory Tract Infections; Severity of Illness Index	2004
Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities. Journal of the American Geriatrics Society, 2005, Volume: 53, Issue:3 Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Canada; Cost-Benefit Analysis; Decision Support Techniques; Disease Outbreaks; Humans; Influenza, Human; Long-Term Care; Models, Economic; Nursing Homes; Oseltamivir	2005
Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-01, Volume: 40, Issue:9 Topics: Acetamides; Adolescent; Adult; Aged; Aging; Amantadine; Antiviral Agents; Child; Child, Preschool; Female; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Japan; Male; Middle Aged; Oseltamivir; Sex Characteristics	2005
Statement on influenza vaccination for the 2005-2006 season. An advisory committee statement. Canada communicable disease report = Releve des maladies transmissibles au Canada, 2005, Jun-15, Volume: 31, Issue:ACS-6 Topics: Acetamides; Adolescent; Age Factors; Amantadine; Animals; Antiviral Agents; Canada; Child; Child, Preschool; Female; Health Personnel; Humans; Infant; Influenza A virus; Influenza B virus; Influenza in Birds; Influenza Vaccines; Influenza, Human; Male; Oseltamivir; Poultry; Pregnancy; Risk Factors; Time Factors	2005
Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors. Medical microbiology and immunology, 2006, Volume: 195, Issue:2 Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Chick Embryo; Chickens; Enzyme Inhibitors; Guanidines; Influenza A virus; Influenza in Birds; Microbial Sensitivity Tests; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2006
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants. Antiviral research, 2006, Volume: 70, Issue:3 Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Cell Line; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Mutation; Oseltamivir; Viral Plaque Assay	2006
Emergence of drug-resistant influenza virus: population dynamical considerations. Science (New York, N.Y.), 2006, Apr-21, Volume: 312, Issue:5772 Topics: Acetamides; Amantadine; Antiviral Agents; Computer Simulation; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Mathematics; Models, Biological; Mutation; Neuraminidase; Orthomyxoviridae; Oseltamivir; Population Dynamics	2006
Update on influenza vaccination for the 2005-2006 season. An Advisory Committee Statement (ACS). Canada communicable disease report = Releve des maladies transmissibles au Canada, 2006, Mar-01, Volume: 32, Issue:ACS-2 Topics: Acetamides; Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H3N2 Subtype; Influenza Vaccines; Influenza, Human; Oseltamivir	2006
Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS). Canada communicable disease report = Releve des maladies transmissibles au Canada, 2006, Jun-15, Volume: 32, Issue:ACS-7 Topics: Acetamides; Adolescent; Adult; Aged; Amantadine; Animals; Antiviral Agents; Canada; Child; Child, Preschool; Contraindications; Disease Outbreaks; Drug Resistance, Viral; Female; Health Personnel; Humans; Immunization Schedule; Infant; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza in Birds; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Oseltamivir; Poultry; Pregnancy	2006
An off-seasonal amantadine-resistant H3N2 influenza outbreak in Japan. The Tohoku journal of experimental medicine, 2006, Volume: 210, Issue:1 Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Amino Acid Substitution; Antiviral Agents; Child; Child, Preschool; Disease Outbreaks; Drug Resistance, Viral; Female; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Infant; Influenza A Virus, H3N2 Subtype; Influenza, Human; Japan; Male; Middle Aged; Molecular Sequence Data; Oseltamivir; Phylogeny; Seasons; Treatment Outcome; Viral Matrix Proteins	2006
Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral research, 2007, Volume: 73, Issue:3 Topics: Acids, Carbocyclic; Amantadine; Animals; Antiviral Agents; Base Sequence; Birds; Cyclopentanes; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Neuraminidase; Oseltamivir; Zanamivir	2007
Antiviral management of seasonal and pandemic influenza. The Journal of infectious diseases, 2006, Nov-01, Volume: 194 Suppl 2 Topics: Amantadine; Animals; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza, Human; Mice; Neuraminidase; Oseltamivir; Rimantadine; Seasons; Zanamivir	2006
[Significance of virological diagnostics for the effective treatment of hospitalized patients infected with influenza virus]. Pneumonologia i alergologia polska, 2006, Volume: 74, Issue:2 Topics: Adult; Amantadine; Antiviral Agents; Diagnosis, Differential; Fluorescent Antibody Technique; Hospitalization; Humans; Influenza A virus; Influenza, Human; Middle Aged; Oseltamivir; Respiratory Tract Diseases; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; Treatment Outcome; Zanamivir	2006
Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best. Prescrire international, 2007, Volume: 16, Issue:87 Topics: Amantadine; Antiviral Agents; Child; Drug Approval; Drug Resistance; Europe; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Vaccination; Zanamivir	2007
Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999. Antiviral research, 2007, Volume: 75, Issue:3 Topics: Amantadine; Amino Acid Substitution; Animals; Antiviral Agents; Cell Line; Drug Resistance, Viral; Enzyme Inhibitors; Germany; Hemagglutination, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Influenza A Virus, H3N2 Subtype; Neuraminidase; Oseltamivir; Swine; Zanamivir	2007
New strain of influenza A virus (H5N1), Thailand. Emerging infectious diseases, 2007, Volume: 13, Issue:3 Topics: Amantadine; Animals; Antigens, Viral; Antiviral Agents; Chickens; Disease Outbreaks; Genes, Viral; Genome, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Male; Microbial Sensitivity Tests; Oseltamivir; Phylogeny; Sequence Analysis; Species Specificity; Thailand	2007
Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antiviral therapy, 2007, Volume: 12, Issue:3 Topics: Administration, Oral; Amantadine; Animals; Antiviral Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance, Viral; Drug Therapy, Combination; Female; Influenza A Virus, H5N1 Subtype; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Orthomyxoviridae Infections; Oseltamivir	2007
Low dose oral combination chemoprophylaxis with oseltamivir and amantadine for influenza A virus infections in mice. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:3 Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Dogs; Dose-Response Relationship, Drug; Drug Combinations; Female; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir	2007
Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives. Antiviral research, 2007, Volume: 76, Issue:2 Topics: Amantadine; Animals; Catechin; Cell Line; Chickens; Dogs; Drug Evaluation, Preclinical; Eggs; Hemagglutination Inhibition Tests; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H2N2 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H9N2 Subtype; Influenza B virus; Molecular Structure; Oseltamivir; Structure-Activity Relationship; Viral Plaque Assay; Virus Attachment; Virus Internalization; Virus Replication	2007
A change in the effectiveness of amantadine for the treatment of influenza over the 2003-2004, 2004-2005, and 2005-2006 influenza seasons in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2007, Volume: 13, Issue:5 Topics: Adolescent; Adult; Age Factors; Amantadine; Child; Child, Preschool; Disease Outbreaks; Drug Resistance, Viral; Female; Humans; Infant; Influenza A virus; Influenza, Human; Japan; Male; Middle Aged; Oseltamivir; Retrospective Studies; Seasons	2007
Influenza. Canadian family physician Medecin de famille canadien, 2008, Volume: 54, Issue:3 Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Mass Vaccination; Oseltamivir; Rimantadine; Zanamivir	2008
Influenza in Canada: 2006-2007 season. Canada communicable disease report = Releve des maladies transmissibles au Canada, 2008, Volume: 34, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Canada; Child; Child, Preschool; Drug Resistance, Viral; Hospitalization; Humans; Infant; Influenza A virus; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Middle Aged; Oseltamivir; Seasons; Sentinel Surveillance	2008
Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B. Statistics in medicine, 2008, Nov-29, Volume: 27, Issue:27 Topics: Amantadine; Antiviral Agents; Bayes Theorem; Clinical Trials as Topic; Decision Support Techniques; Follow-Up Studies; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Markov Chains; Meta-Analysis as Topic; Monte Carlo Method; Oseltamivir; Statistics as Topic; Time Factors; Treatment Outcome	2008
Antivirals and influenza: frequency of resistance. The Pediatric infectious disease journal, 2008, Volume: 27, Issue:10 Suppl Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Zanamivir	2008
Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam. PloS one, 2008, Oct-06, Volume: 3, Issue:10 Topics: Adolescent; Adult; Amantadine; Antiviral Agents; Child; Child, Preschool; Disease Outbreaks; Drug Resistance, Viral; Female; Geography; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Male; Oseltamivir; Phylogeny; Retrospective Studies; Vietnam	2008
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Amantadine; Animals; Antiviral Agents; Birds; Drug Resistance, Viral; Genetic Markers; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, RNA; Zanamivir	2009
Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; Humans; Influenza A Virus, H5N1 Subtype; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Orthomyxoviridae Infections; Oseltamivir; Ribavirin; Specific Pathogen-Free Organisms; Treatment Outcome	2009
Oseltamivir- and amantadine-resistant influenza viruses A (H1N1). Emerging infectious diseases, 2009, Volume: 15, Issue:6 Topics: Amantadine; Antiviral Agents; Cell Line; Drug Resistance, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Hong Kong; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Phylogeny; Polymerase Chain Reaction; Population Surveillance; Sequence Analysis, DNA	2009
Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10 Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Dogs; Drug Synergism; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Orthomyxoviridae; Oseltamivir; Polymerase Chain Reaction; Ribavirin	2009
Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand. Biochemical and biophysical research communications, 2009, Dec-18, Volume: 390, Issue:3 Topics: Amantadine; Antiviral Agents; Drug Resistance, Multiple, Viral; Genes, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mutation; Oseltamivir; Phylogeny; Thailand	2009
Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases. PloS one, 2009, Dec-17, Volume: 4, Issue:12 Topics: Amantadine; Animals; Aurintricarboxylic Acid; Betainfluenzavirus; Cell Line; Culture Media; Cytoprotection; Dogs; Drug Resistance, Viral; Drug Synergism; Enzyme Inhibitors; Inclusion Bodies, Viral; Influenza A virus; Neuraminidase; Oseltamivir; RNA, Viral; Virus Inactivation; Virus Replication	2009
Oseltamivir- and amantadine-resistant influenza virus A (H1N1). Emerging infectious diseases, 2010, Volume: 16, Issue:1 Topics: Amantadine; Antiviral Agents; Drug Resistance, Multiple, Viral; Hong Kong; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir	2010
Antiviral drug profile of seasonal influenza viruses circulating in Portugal from 2004/2005 to 2008/2009 winter seasons. Antiviral research, 2010, Volume: 86, Issue:2 Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Inhibitory Concentration 50; Male; Middle Aged; Oseltamivir; Portugal; RNA, Viral; Sequence Analysis; Young Adult	2010
Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses. Journal of clinical microbiology, 2010, Volume: 48, Issue:4 Topics: Amantadine; Amino Acid Substitution; Antiviral Agents; Cluster Analysis; Genome, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Molecular Sequence Data; Mutation, Missense; Oseltamivir; Phylogeny; RNA, Viral; Sequence Analysis, DNA; Sequence Homology; Viral Proteins	2010
Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro. PloS one, 2010, Feb-22, Volume: 5, Issue:2 Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Drug Resistance, Viral; Drug Synergism; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Inhibitory Concentration 50; Orthomyxoviridae; Oseltamivir; Ribavirin	2010
Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstetrics and gynecology, 2010, Volume: 115, Issue:4 Topics: Amantadine; Antiviral Agents; Enterocolitis, Necrotizing; Female; Humans; Infant, Newborn; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Rimantadine	2010
Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan. Emerging infectious diseases, 2010, Volume: 16, Issue:6 Topics: Amantadine; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Hemagglutination Inhibition Tests; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Neuraminidase; Oseltamivir; Phylogeny; Seasons; Sequence Analysis, Protein; Time Factors; Viral Matrix Proteins; Zanamivir	2010
Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season. Journal of medical virology, 2010, Volume: 82, Issue:7 Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Child, Preschool; Dogs; Drug Resistance, Viral; Environmental Monitoring; Epidemiological Monitoring; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Lebanon; Male; Microbial Sensitivity Tests; Oseltamivir; Phylogeny; Seasons; Zanamivir	2010
Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants. Chemosphere, 2010, Volume: 81, Issue:1 Topics: Amantadine; Antiviral Agents; Chromatography, Liquid; Environmental Monitoring; Oseltamivir; Ozone; Sewage; Tandem Mass Spectrometry; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Pollution, Chemical	2010
[Naturally occurring oseltamivir resistance in influenza A]. Ugeskrift for laeger, 2010, Aug-09, Volume: 172, Issue:32 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Zanamivir	2010
Inhibition of influenza virus replication by plant-derived isoquercetin. Antiviral research, 2010, Volume: 88, Issue:2 Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Drug Evaluation, Preclinical; Drug Resistance, Viral; Drug Synergism; Equisetum; Female; Humans; Hypericum; Influenza A virus; Influenza B virus; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Plant Extracts; Quercetin; Vero Cells; Virus Replication	2010
Prolonged shedding of amantadine- and oseltamivir-resistant influenza A(H3N2) virus with dual mutations in an immunocompromised infant. Antiviral therapy, 2010, Volume: 15, Issue:7 Topics: Amantadine; Amino Acid Sequence; Antiviral Agents; Drug Resistance, Multiple, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Immunocompromised Host; Infant; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Molecular Sequence Data; Mutation; Neuraminidase; Oseltamivir; Viral Matrix Proteins	2010
Comparison of the efficacies of amantadine treatment of swine-origin influenza virus A H1N1 and seasonal influenza H1N1 and H3N2 in Japan (2008-2009). Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:4 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Amantadine; Amino Acid Sequence; Analysis of Variance; Antiviral Agents; Body Temperature; Child; Child, Preschool; Disease Outbreaks; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Japan; Middle Aged; Molecular Sequence Data; Mutation; Oseltamivir; Seasons; Sequence Alignment; Treatment Outcome; Viral Matrix Proteins; Zanamivir	2011
Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Cohort Studies; Critical Illness; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Korea; Male; Middle Aged; Oseltamivir; Pandemics; Respiration, Artificial; Retrospective Studies; Ribavirin; Treatment Outcome	2011
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009. The Journal of infectious diseases, 2011, Dec-15, Volume: 204, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Guideline Adherence; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Odds Ratio; Oseltamivir; Pandemics; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Rimantadine; United States; Young Adult; Zanamivir	2011
Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus. PloS one, 2011, Volume: 6, Issue:12 Topics: Amantadine; Amino Acid Substitution; Animals; Antiviral Agents; Cell Line; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Influenza A virus; Oseltamivir; Phenotype; Ribavirin; Serial Passage; Suppression, Genetic	2011
Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. PloS one, 2012, Volume: 7, Issue:1 Topics: Amantadine; Animals; Antiviral Agents; Cells, Cultured; Disease Models, Animal; Dogs; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Female; Influenza A Virus, H5N1 Subtype; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Placebos; Ribavirin; Treatment Outcome	2012
Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein. Journal of medicinal chemistry, 2012, Mar-08, Volume: 55, Issue:5 Topics: Amantadine; Amides; Animals; Antiviral Agents; Cell Line; Dogs; Drug Design; Drug Resistance, Viral; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Models, Molecular; Nucleoproteins; Oseltamivir; Piperazines; Structure-Activity Relationship; Triazoles; Viral Core Proteins; Viral Plaque Assay; Virus Replication	2012
Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008. Revista panamericana de salud publica = Pan American journal of public health, 2011, Volume: 30, Issue:6 Topics: Amantadine; Animals; Antiviral Agents; Argentina; Cell Line; Dogs; Drug Resistance, Multiple, Viral; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Morbidity; Mutation, Missense; Neuraminidase; Oseltamivir; Point Mutation; Population Surveillance; Seasons; Virus Cultivation; Zanamivir	2011
[A genetic analysis of A H1N1 pandemic influenza virus in the course of the epidemic]. Terapevticheskii arkhiv, 2012, Volume: 84, Issue:3 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Genetic Testing; Genome, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pandemics; Polymorphism, Genetic; Prognosis; Russia	2012
Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents. Antiviral research, 2012, Volume: 96, Issue:1 Topics: Amantadine; Animals; Antiviral Agents; Disease Models, Animal; Drug Resistance, Viral; Female; Influenza A Virus, H1N1 Subtype; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Survival Analysis; Treatment Outcome	2012
Synchronous dynamics of observed and predicted values of anti-influenza drugs in environmental waters during a seasonal influenza outbreak. Environmental science & technology, 2012, Dec-04, Volume: 46, Issue:23 Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Environmental Monitoring; Humans; Influenza, Human; Japan; Oseltamivir; Rivers; Sewage; Water Pollutants, Chemical; Zanamivir	2012
Delayed emergence of oseltamivir-resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar. Influenza and other respiratory viruses, 2013, Volume: 7, Issue:5 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Myanmar; Oseltamivir; Pandemics; Phylogeny; Seasons	2013
[Establishment of drug screening assay and pharmacodynamic evaluation method targeting influenza RNA polymerase]. Yao xue xue bao = Acta pharmaceutica Sinica, 2012, Volume: 47, Issue:9 Topics: Alphainfluenzavirus; Amantadine; Antiviral Agents; Drug Evaluation, Preclinical; Genes, Reporter; HEK293 Cells; Humans; Luciferases; Oseltamivir; Plasmids; Reproducibility of Results; Ribavirin; RNA-Dependent RNA Polymerase; Sensitivity and Specificity; Transfection; Zanamivir	2012
Simultaneous detection of oseltamivir- and amantadine-resistant influenza by oligonucleotide microarray visualization. PloS one, 2013, Volume: 8, Issue:2 Topics: Amantadine; Antiviral Agents; Base Sequence; Cost-Benefit Analysis; DNA Primers; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Oligonucleotide Array Sequence Analysis; Oseltamivir; Polymerase Chain Reaction	2013
Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses. Antiviral research, 2013, Volume: 99, Issue:3 Topics: Amantadine; Animals; Antiviral Agents; Benzodioxoles; Drug Therapy, Combination; Drugs, Chinese Herbal; Endosomes; Enzyme Inhibitors; Humans; Influenza, Human; Lignans; Magnoliopsida; Membrane Fusion; Orthomyxoviridae; Oseltamivir; Vacuolar Proton-Translocating ATPases; Virus Replication	2013
Mass balance of anti-influenza drugs discharged into the Yodo River system, Japan, under an influenza outbreak. Chemosphere, 2013, Volume: 93, Issue:9 Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Environmental Monitoring; Humans; Influenza, Human; Japan; Oseltamivir; Rivers; Water Pollutants, Chemical	2013
Virological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A (H1N1) infection. Japanese journal of infectious diseases, 2013, Volume: 66, Issue:5 Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Respiratory Distress Syndrome; Ribavirin; Survival Analysis; Treatment Outcome	2013
Prevalence, genetic drift of haemagglutinin, and antiviral resistance of influenza A/H3N2 viruses circulating in Shanghai in children during 2009-2012. Journal of medical virology, 2014, Volume: 86, Issue:6 Topics: Adolescent; Amantadine; Antiviral Agents; Child; Child, Preschool; China; Cluster Analysis; Drug Resistance, Viral; Female; Genetic Drift; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Infant; Infant, Newborn; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mutation, Missense; Nasopharynx; Oseltamivir; Phylogeny; Prevalence; RNA, Viral; Sequence Analysis, DNA; Sequence Homology	2014
The combination of ribavirin and ozeltamivir effectively inhibits reproduction of influenza A virus resistant to rimantadine (amantadine) in vitro and in vivo. Doklady. Biochemistry and biophysics, 2014, Volume: 455, Issue:1 Topics: Amantadine; Animals; Antiviral Agents; Dogs; Drug Combinations; Drug Resistance, Viral; Influenza A virus; Madin Darby Canine Kidney Cells; Mice; Orthomyxoviridae Infections; Oseltamivir; Ribavirin; Virus Replication	2014
Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011. The Indian journal of medical research, 2014, Volume: 140, Issue:2 Topics: Amantadine; Base Sequence; Cluster Analysis; Drug Resistance, Viral; Genetic Markers; Humans; India; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Models, Genetic; Molecular Sequence Data; Mutation, Missense; Oseltamivir; Phylogeny; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA	2014
Characterization of human Influenza Viruses in Lebanon during 2010-2011 and 2011-2012 post-pandemic seasons. Intervirology, 2014, Volume: 57, Issue:6 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Lebanon; Microbial Sensitivity Tests; Mutation; Neuraminidase; Oseltamivir; Pandemics; Phylogeny; Pyrans; Sialic Acids; Zanamivir	2014
Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2015, Volume: 29 Topics: Amantadine; Animals; Antiviral Agents; Dogs; Drug Resistance, Viral; Humans; India; Influenza A Virus, H3N2 Subtype; Influenza, Human; Madin Darby Canine Kidney Cells; Mutation; Nasopharynx; Neuraminidase; Oseltamivir; Pandemics; Phylogeny; Viral Matrix Proteins	2015
H5N1 virus resistant to antiviral drug. Hong Kong medical journal = Xianggang yi xue za zhi, 2015, Volume: 21 Suppl 4 Topics: Amantadine; Antiviral Agents; Asia; Drug Resistance, Viral; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Mutation; Oseltamivir	2015
Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses. Antiviral research, 2016, Volume: 129 Topics: Amantadine; Antibody-Dependent Enhancement; Antiviral Agents; Coronavirus Infections; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Picornaviridae Infections; Respiratory Tract Infections; Rimantadine; Severe Acute Respiratory Syndrome; Texas; Virus Replication	2016
Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers. Molecular pharmacology, 2016, Volume: 90, Issue:3 Topics: Amantadine; Animals; Antiviral Agents; Base Sequence; Dogs; Drug Resistance, Multiple; Drug Resistance, Viral; Genes, Viral; Humans; Influenza A Virus, H1N1 Subtype; Inhibitory Concentration 50; Ion Channel Gating; Kinetics; Madin Darby Canine Kidney Cells; Membrane Transport Modulators; Mutant Proteins; Oseltamivir; Sequence Analysis, DNA; Serial Passage; Viral Matrix Proteins	2016
Development and application of an in-cell cleanup pressurized liquid extraction with ultra-high-performance liquid chromatography-tandem mass spectrometry to detect prohibited antiviral agents sensitively in livestock and poultry feces. Journal of chromatography. A, 2017, Mar-10, Volume: 1488 Topics: Adsorption; Amantadine; Animals; Antiviral Agents; Chromatography, High Pressure Liquid; Feces; Limit of Detection; Livestock; Oseltamivir; Poultry; Pressure; Reproducibility of Results; Solvents; Tandem Mass Spectrometry	2017
[Similarity of Clinically Significant Neuropsychiatric Adverse Reactions Listed in Package Inserts between the Anti-influenza Drugs Oseltamivir and Amantadine (Possibility Attributable to Common Pharmacological Effects)]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2018, Sep-01, Volume: 138, Issue:9 Topics: Amantadine; Antiviral Agents; Dopamine Agonists; Drug Labeling; Enzyme Inhibitors; Humans; Influenza, Human; Mental Disorders; Molecular Conformation; Nervous System Diseases; Neuraminidase; Nicotinic Antagonists; Oseltamivir	2018
Clinically Relevant Influenza Virus Evolution Reconstituted in a Human Lung Airway-on-a-Chip. Microbiology spectrum, 2021, 10-31, Volume: 9, Issue:2 Topics: Amantadine; Antiviral Agents; Benzamidines; Drug Resistance, Viral; Evolution, Molecular; Guanidines; Humans; Influenza A virus; Influenza, Human; Lab-On-A-Chip Devices; Lung; Microfluidics; Oseltamivir; SARS-CoV-2	2021